Inventor

EIFLER René

DE14 patents

⚠️ This page may combine multiple inventors who share the name “EIFLER René”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LTS LOHMANN THERAPIE SYSTEME AG

11 patents

US10980753B2Apr 20, 2021

Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene

LTS LOHMANN THERAPIE SYSTEME AG4 citations71

US11033512B2Jun 15, 2021

Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer

LTS LOHMANN THERAPIE SYSTEME AG5 citations71

US12485099B2Dec 2, 2025

Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene

LTS LOHMANN THERAPIE SYSTEME AG0 citations60

US12138353B2Nov 12, 2024

Transdermal therapeutic system containing asenapine

LTS LOHMANN THERAPIE SYSTEME AG0 citations60

US12433851B2Oct 7, 2025

Controlling water release from a dimensionally stable aqueous composition

LTS LOHMANN THERAPIE SYSTEME AG0 citations57

US11752109B2Sep 12, 2023

Controlling water release from a dimensionally stable aqueous composition

LTS LOHMANN THERAPIE SYSTEME AG0 citations57

US12329862B2Jun 17, 2025

Transdermal therapeutic system containing asenapine

LTS LOHMANN THERAPIE SYSTEME AG0 citations50

US9526736B2Dec 27, 2016

Transdermal therapeutic system comprising norelgestromin for contraception and hormone replacement

LTS LOHMANN THERAPIE SYSTEME AG0 citations49

EIFLER René

1 patent

US9833418B2Dec 5, 2017

Transdermal therapeutic system having controlled active substance flow comprising a basic reacting oxide

EIFLER René2 citations62

EIFLER RENE

1 patent

US10363228B2Jul 30, 2019

Transdermal administration of memantine

EIFLER RENE1 citations46

THEOBALD FRANK

1 patent

US9220691B2Dec 29, 2015

Transdermal therapeutic system comprising norelestromin for contraception and hormone replacement

THEOBALD FRANK0 citations43